Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

NCT05067946 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Change of development strategy in consideration of the global COVID-19 situation

Conditions

Interventions

Sponsor

Genexine, Inc.

Collaborators